Login| Sign Up| Help| Contact|

Patent Searching and Data


Title:
UREA DERIVATIVES WITH ANTIPROTEOLYTIC ACTIVITY
Document Type and Number:
WIPO Patent Application WO2003002524
Kind Code:
A3
Abstract:
The present invention relates to compounds of the formula I, in which R<1>, R<2>, R<4>, R<5>, D1, D2, X1, X2, X3, A and B have the meanings indicated in the claims. The compounds of the formula I are valuable pharmacologically active compounds. They exhibit a strong antithrombotic effect and are suitable, for example, for the therapy and prophylaxis of thromboembolic diseases and restenoses. They are reversible inhibitors of the blood clotting enzyme factor VIIa and can in general be applied in conditions in which an undesired activity of factor VIIa is present or for the cure or prevention of which an inhibition of factor VIIa is intended. The invention furthermore relates to processes for the preparation of compounds of the formula (I), their use, in particular as active ingredients in pharmaceuticals, and pharmaceutical preparations comprising them.

Inventors:
SCHUDOK MANFRED
KLINGLER OTMAR
NESTLER HANS-PETER
MATTER HANS
SCHREUDER HERMAN
SZILLAT HAUKE
Application Number:
PCT/EP2002/006422
Publication Date:
March 11, 2004
Filing Date:
June 12, 2002
Export Citation:
Click for automatic bibliography generation   Help
Assignee:
AVENTIS PHARMA GMBH (DE)
International Classes:
C07D295/18; A61K31/17; A61K31/192; A61K31/275; A61K31/343; A61K31/357; A61K31/381; A61K31/4406; A61K31/4409; A61K31/5375; A61P7/00; A61P7/02; A61P9/00; A61P9/10; A61P29/00; C07C275/40; C07C275/42; C07C317/10; C07D213/40; C07D213/74; C07D307/88; C07D319/18; C07D333/36; C07D333/38; C07D333/40; (IPC1-7): C07C275/42; C07D333/38; A61K31/17; A61P7/00
Domestic Patent References:
WO1994017041A11994-08-04
WO1994022907A11994-10-13
Foreign References:
EP0987274A12000-03-22
Download PDF: